NeuroNEXT

Broad Institute has made an official press release announcing the beginning of enrollment for PRiSM(NN112). NN112 is a gene therapy clinical trial investigating, for the first time in humans, a potential treatment for a rare Prion disease. The drug being tested is a siRNA molecule that was designed to slow the cells production of the…

Dr. Sonia Vallabh, in preparation for the first clinical trial for Prion disease, was featured on the on the front of the NIH Record’s January edition. The full article can be found by following the link below. In addition to the NIH Record article discussing this major milestone for Prion disease, Dr. Vallabh was also…

The National Institute of Neurological Disorders and Stroke (NINDS) is pleased to invite you to the Preclinical Common Data Elements (CDE)/Data Standards Webinar Series Kick-off on January 28, 2026.  This new monthly webinar series is designed to be interactive and to engage researchers and stakeholders with up-to-date information on preclinical common data elements (CDEs) and…

The CTMC Executive Committee is pleased to announce the call for applications for the 2026 cohort of the NINDS Clinical Trials Methodology Course (CTMC). Now in its 14th year, the goal of the CTMC is to train early career investigators to develop scientifically rigorous, feasible, and ethically designed clinical trials. CTMC participants will learn best practices in clinical…

Fueled by her compassion and relentless dedication, Dr. Merit Cudkowicz, was honored with the AAN Lifetime Achievement Award for Clinically Relevant Research this past Spring for her unwavering commitment to improving the lives of her patients and community. Her work has not only elevated standards of care but also inspired countless others in the field,…

In an article published in the recent issue of Brain and Life (a magazine managed by the American Academy of Neurology) an article commemorating the 75th anniversary of NINDS mentioned NeuroNEXT by name. To read the full article, click here. Thank you to all NeuroNEXT members and participants, past and present, for your hard work…

We are pleased to announce the call for applications for the 2025 cohort of the NINDS Clinical Trials Methodology Course (CTMC). Now in its 13th year, the overall goal of the CTMC is to train early career investigators to develop scientifically rigorous, feasible, and ethically designed clinical trials. CTMC participants will learn best practices in clinical trial design…

You’re invited to an upcoming event entitled “NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) Informational Webinar”, occurring on December 16th from 12-1pm ET.  Dr. Sophie Cho and Joan Ohayon, along with our esteemed panel, will provide an update to recently reissued Notice of Funding Opportunity (NOFO) for the NeuroNEXT Small Business Innovation in…

Hello! We invite you and your community to virtually join us for the second NIH/NINDS Team Science Seminar Series on Thursday December 12 from 12-2PM (Eastern). Registration and event details here! Seats are limited, so be sure to register early! The NIH/NINDS Team Science Seminar Series facilitates knowledge generation and translation through a dialogical approach…

The AAN is hosting a Heath Care Equity Webinar Series in response to member interest in more opportunities to learn about topics related to Diversity, Equity, and Inclusion (DEI) while earning valuable CME credits. We hope you will join us for our first webinar on Thursday, November 7, from 1:00 p.m.–2:00 p.m. CT for “Neurodiversity…